Lipidomics, Pathobiology and Therapy Center
of Economic Excellence

Inception:
2009
About the CoEE:
This CoEE takes advantage of MUSC’s strength in the area of lipidomics, which involves the study of lipids within biological systems. Lipids, along with carbohydrates and proteins, are one of the principle components of living cells and include fats, waxes, and similar compounds.
The CoEE will translate the basic lipidomics research occurring at MUSC into an understanding of how lipids play a role in health problems such as cancer, inflammation, and diabetes. Researchers will then use that understanding to identify new targets for diagnostics or treatments for these illnesses.
The CoEE has filed three invention disclosures, two focused on
detection and monitoring of bladder cancer and one focused on blood screenings and identification of disease biomarkers.
The CoEE is working to generate additional external research funding for MUSC’s lipid research program and could lead to the development of patents that can be licensed, sold, or serve as the basis for new start-up companies.
Funding level:
$5 million
CoEE Endowed Chairs:
| Chair Name |
|
Status |
| CoEE Endowed Chair in Lipidomics and Pathobiology |
|
Actively recruiting |
| CoEE Endowed Chair in Lipidomics and Drug Discovery |
|
Actively recruiting |
|